Updated COVID-19 vaccines are arriving for the fall and winter season. Experts say you should get vaccinated, but you may not need to rush to receive the shot.

Paxlovid was linked with a 26% lower risk of long Covid, a 47% lower risk of death and a 24% lower risk of hospitalization 30 days after an initial infection.

Paxlovid is transitioning to the commercial market. Like COVID vaccines (more on that below), Paxlovid supplies in the United States are moving away from being bought by the federal government and ...

COVID antiviral Paxlovid to see price increase following 400% vaccine hike The new price is not set, but one analyst suggested it could be up to 5x higher.

Implications of commercializing COVID-19 vaccines, treatments 04:53. Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent ...

The antiviral pill Paxlovid does not significantly reduce COVID-19 hospitalizations in vaccinated older adults, according to new research by UCLA doctors. The findings, published Thursday in a ...

Pfizer reported $12.5 billion in Paxlovid and COVID vaccine sales in 2023, after a $57 billion peak in 2022. The company's 2024 Super Bowl ad, which cost an estimated $14 million to place, ...

Vaccines and treatments together offer optimal protection against covid’s severe outcomes. Each reduces the risk of hospitalization and death, though Paxlovid probably has the greater effect.

Pfizer generated nearly $57 billion in combined sales last year from its Comirnaty Covid-19 vaccine and Paxlovid antiviral pill. That works out to almost 60% of the company’s total revenue for 2022.

With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients. By Christina Jewett As Covid rises again, killing about 1,500 ...